-
1
-
-
70049112901
-
Guidelines for the diagnosis and treatment of pulmonary hypertension: The Task Force for the Diagnosis and Treatment of Pulmonary Hypertension of the European Society of Cardiology (ESC) and the European Respiratory Society (ERS), endorsed by the International Society of Heart and Lung Transplantation (ISHLT)
-
N. Galie, M.M. Hoeper, and M. Humbert Guidelines for the diagnosis and treatment of pulmonary hypertension: the Task Force for the Diagnosis and Treatment of Pulmonary Hypertension of the European Society of Cardiology (ESC) and the European Respiratory Society (ERS), endorsed by the International Society of Heart and Lung Transplantation (ISHLT) Eur Heart J 30 2009 2493 2537
-
(2009)
Eur Heart J
, vol.30
, pp. 2493-2537
-
-
Galie, N.1
Hoeper, M.M.2
Humbert, M.3
-
2
-
-
64849109410
-
ACCF/AHA 2009 expert consensus document on pulmonary hypertension: A report of the American College of Cardiology Foundation Task Force on Expert Consensus Documents and the American Heart Association
-
V.V. McLaughlin, S.L. Archer, and D.B. Badesch ACCF/AHA 2009 expert consensus document on pulmonary hypertension: a report of the American College of Cardiology Foundation Task Force on Expert Consensus Documents and the American Heart Association J Am Coll Cardiol 53 2009 1573 1619
-
(2009)
J Am Coll Cardiol
, vol.53
, pp. 1573-1619
-
-
McLaughlin, V.V.1
Archer, S.L.2
Badesch, D.B.3
-
3
-
-
67649624517
-
Pulmonary arterial pressure during rest and exercise in healthy subjects: A systematic review
-
G. Kovacs, A. Berghold, and S. Scheidl Pulmonary arterial pressure during rest and exercise in healthy subjects: a systematic review Eur Respir J 34 2009 888 894
-
(2009)
Eur Respir J
, vol.34
, pp. 888-894
-
-
Kovacs, G.1
Berghold, A.2
Scheidl, S.3
-
5
-
-
84890738424
-
Updated clinical classification of pulmonary hypertension
-
G. Simonneau, M.A. Gatzoulis, and I. Adatia Updated clinical classification of pulmonary hypertension J Am Coll Cardiol 62 2013 D34 D41
-
(2013)
J Am Coll Cardiol
, vol.62
, pp. D34-D41
-
-
Simonneau, G.1
Gatzoulis, M.A.2
Adatia, I.3
-
6
-
-
33748314526
-
High frequency of BMPR2 exonic deletions/duplications in familial pulmonary arterial hypertension
-
J.D. Cogan, M.W. Pauciulo, and A.P. Batchman High frequency of BMPR2 exonic deletions/duplications in familial pulmonary arterial hypertension Am J Respir Crit Care Med 174 2006 590 598
-
(2006)
Am J Respir Crit Care Med
, vol.174
, pp. 590-598
-
-
Cogan, J.D.1
Pauciulo, M.W.2
Batchman, A.P.3
-
7
-
-
0033623296
-
Sporadic primary pulmonary hypertension is associated with germline mutations of the gene encoding BMPR-II, a receptor member of the TGF-beta family
-
J.R. Thomson, R.D. Machado, and M.W. Pauciulo Sporadic primary pulmonary hypertension is associated with germline mutations of the gene encoding BMPR-II, a receptor member of the TGF-beta family J Med Genet 37 2000 741 745
-
(2000)
J Med Genet
, vol.37
, pp. 741-745
-
-
Thomson, J.R.1
Machado, R.D.2
Pauciulo, M.W.3
-
8
-
-
9144219585
-
Molecular and functional analysis identifies ALK-1 as the predominant cause of pulmonary hypertension related to hereditary haemorrhagic telangiectasia
-
R.E. Harrison, J.A. Flanagan, and M. Sankelo Molecular and functional analysis identifies ALK-1 as the predominant cause of pulmonary hypertension related to hereditary haemorrhagic telangiectasia J Med Genet 40 2003 865 871
-
(2003)
J Med Genet
, vol.40
, pp. 865-871
-
-
Harrison, R.E.1
Flanagan, J.A.2
Sankelo, M.3
-
9
-
-
84864330965
-
Whole exome sequencing to identify a novel gene (caveolin-1) associated with human pulmonary arterial hypertension
-
E.D. Austin, L. Ma, and C. LeDuc Whole exome sequencing to identify a novel gene (caveolin-1) associated with human pulmonary arterial hypertension Circ Cardiovasc Genet 5 2012 336 343
-
(2012)
Circ Cardiovasc Genet
, vol.5
, pp. 336-343
-
-
Austin, E.D.1
Ma, L.2
Leduc, C.3
-
10
-
-
84880704857
-
A novel channelopathy in pulmonary arterial hypertension
-
L. Ma, D. Roman-Campos, and E.D. Austin A novel channelopathy in pulmonary arterial hypertension N Engl J Med 369 2013 351 361
-
(2013)
N Engl J Med
, vol.369
, pp. 351-361
-
-
Ma, L.1
Roman-Campos, D.2
Austin, E.D.3
-
11
-
-
0021986849
-
Aminorex and pulmonary hypertension. A review
-
H.P. Gurtner Aminorex and pulmonary hypertension. A review Cor Vasa 27 1985 160 171
-
(1985)
Cor Vasa
, vol.27
, pp. 160-171
-
-
Gurtner, H.P.1
-
12
-
-
40649100110
-
Pulmonary arterial hypertension associated with fenfluramine exposure: Report of 109 cases
-
R. Souza, M. Humbert, and B. Sztrymf Pulmonary arterial hypertension associated with fenfluramine exposure: report of 109 cases Eur Respir J 31 2008 343 348
-
(2008)
Eur Respir J
, vol.31
, pp. 343-348
-
-
Souza, R.1
Humbert, M.2
Sztrymf, B.3
-
13
-
-
84868541077
-
Pulmonary hypertension associated with benfluorex exposure
-
L. Savale, M.C. Chaumais, and V. Cottin Pulmonary hypertension associated with benfluorex exposure Eur Respir J 40 2012 1164 1172
-
(2012)
Eur Respir J
, vol.40
, pp. 1164-1172
-
-
Savale, L.1
Chaumais, M.C.2
Cottin, V.3
-
14
-
-
84860346274
-
Pulmonary arterial hypertension in patients treated by dasatinib
-
D. Montani, E. Bergot, and S. Gunther Pulmonary arterial hypertension in patients treated by dasatinib Circulation 125 2012 2128 2137
-
(2012)
Circulation
, vol.125
, pp. 2128-2137
-
-
Montani, D.1
Bergot, E.2
Gunther, S.3
-
15
-
-
84916241478
-
Pulmonary arterial hypertension in patients treated with interferon
-
L. Savale, C. Sattler, and S. Gunther Pulmonary arterial hypertension in patients treated with interferon Eur Respir J 44 2014 1627 1634
-
(2014)
Eur Respir J
, vol.44
, pp. 1627-1634
-
-
Savale, L.1
Sattler, C.2
Gunther, S.3
-
16
-
-
33646269035
-
Pulmonary arterial hypertension in France: Results from a national registry
-
M. Humbert, O. Sitbon, and A. Chaouat Pulmonary arterial hypertension in France: results from a national registry Am J Respir Crit Care Med 173 2006 1023 1030
-
(2006)
Am J Respir Crit Care Med
, vol.173
, pp. 1023-1030
-
-
Humbert, M.1
Sitbon, O.2
Chaouat, A.3
-
17
-
-
76749135710
-
Pulmonary arterial hypertension: Baseline characteristics from the REVEAL Registry
-
D.B. Badesch, G.E. Raskob, and C.G. Elliott Pulmonary arterial hypertension: baseline characteristics from the REVEAL Registry Chest 137 2010 376 387
-
(2010)
Chest
, vol.137
, pp. 376-387
-
-
Badesch, D.B.1
Raskob, G.E.2
Elliott, C.G.3
-
18
-
-
80155127921
-
Screening for pulmonary arterial hypertension in patients with systemic sclerosis: Clinical characteristics at diagnosis and long-term survival
-
M. Humbert, A. Yaici, and P. de Groote Screening for pulmonary arterial hypertension in patients with systemic sclerosis: clinical characteristics at diagnosis and long-term survival Arthritis Rheum 63 2011 3522 3530
-
(2011)
Arthritis Rheum
, vol.63
, pp. 3522-3530
-
-
Humbert, M.1
Yaici, A.2
De Groote, P.3
-
19
-
-
84902249499
-
Evidence-based detection of pulmonary arterial hypertension in systemic sclerosis: The DETECT study
-
for the DETECT Study Group
-
J.G. Coghlan, C.P. Denton, E. Grunig for the DETECT Study Group Evidence-based detection of pulmonary arterial hypertension in systemic sclerosis: the DETECT study Ann Rheum Dis 73 2014 1340 1349
-
(2014)
Ann Rheum Dis
, vol.73
, pp. 1340-1349
-
-
Coghlan, J.G.1
Denton, C.P.2
Grunig, E.3
-
21
-
-
37849026480
-
Prevalence of HIV-related pulmonary arterial hypertension in the current antiretroviral therapy era
-
O. Sitbon, C. Lascoux-Combe, and J.F. Delfraissy Prevalence of HIV-related pulmonary arterial hypertension in the current antiretroviral therapy era Am J Respir Crit Care Med 177 2008 108 113
-
(2008)
Am J Respir Crit Care Med
, vol.177
, pp. 108-113
-
-
Sitbon, O.1
Lascoux-Combe, C.2
Delfraissy, J.F.3
-
22
-
-
84863519076
-
An evaluation of long-term survival from time of diagnosis in pulmonary arterial hypertension from the REVEAL Registry
-
R.L. Benza, D.P. Miller, and R.J. Barst An evaluation of long-term survival from time of diagnosis in pulmonary arterial hypertension from the REVEAL Registry Chest 142 2012 448 456
-
(2012)
Chest
, vol.142
, pp. 448-456
-
-
Benza, R.L.1
Miller, D.P.2
Barst, R.J.3
-
23
-
-
84857816891
-
Portopulmonary hypertension: A report from the US-based REVEAL Registry
-
M.J. Krowka, D.P. Miller, and R.J. Barst Portopulmonary hypertension: a report from the US-based REVEAL Registry Chest 141 2012 906 915
-
(2012)
Chest
, vol.141
, pp. 906-915
-
-
Krowka, M.J.1
Miller, D.P.2
Barst, R.J.3
-
24
-
-
34249316235
-
Pulmonary arterial hypertension in adults born with a heart septal defect: The Euro Heart Survey on adult congenital heart disease
-
P.M. Engelfriet, M.G. Duffels, and T. Moller Pulmonary arterial hypertension in adults born with a heart septal defect: the Euro Heart Survey on adult congenital heart disease Heart 93 2007 682 687
-
(2007)
Heart
, vol.93
, pp. 682-687
-
-
Engelfriet, P.M.1
Duffels, M.G.2
Moller, T.3
-
25
-
-
62549160153
-
Cardiopulmonary manifestations of hepatosplenic schistosomiasis
-
M. Lapa, B. Dias, and C. Jardim Cardiopulmonary manifestations of hepatosplenic schistosomiasis Circulation 119 2009 1518 1523
-
(2009)
Circulation
, vol.119
, pp. 1518-1523
-
-
Lapa, M.1
Dias, B.2
Jardim, C.3
-
27
-
-
84859496577
-
The role of target therapies in schistosomiasis-associated pulmonary arterial hypertension
-
C.J. Fernandes, B.A. Dias, and C.V. Jardim The role of target therapies in schistosomiasis-associated pulmonary arterial hypertension Chest 141 2012 923 928
-
(2012)
Chest
, vol.141
, pp. 923-928
-
-
Fernandes, C.J.1
Dias, B.A.2
Jardim, C.V.3
-
29
-
-
84891373442
-
EIF2AK4 mutations cause pulmonary veno-occlusive disease, a recessive form of pulmonary hypertension
-
M. Eyries, D. Montani, and B. Girerd EIF2AK4 mutations cause pulmonary veno-occlusive disease, a recessive form of pulmonary hypertension Nat Genet 46 2014 65 69
-
(2014)
Nat Genet
, vol.46
, pp. 65-69
-
-
Eyries, M.1
Montani, D.2
Girerd, B.3
-
30
-
-
84890771619
-
Pulmonary hypertension due to left heart diseases
-
J.L. Vachiery, Y. Adir, and J.A. Barbera Pulmonary hypertension due to left heart diseases J Am Coll Cardiol 62 2013 D100 D108
-
(2013)
J Am Coll Cardiol
, vol.62
, pp. D100-D108
-
-
Vachiery, J.L.1
Adir, Y.2
Barbera, J.A.3
-
31
-
-
2942574709
-
Pathologic assessment of vasculopathies in pulmonary hypertension
-
G.G. Pietra, F. Capron, and S. Stewart Pathologic assessment of vasculopathies in pulmonary hypertension J Am Coll Cardiol 43 2004 25S 32S
-
(2004)
J Am Coll Cardiol
, vol.43
, pp. 25S-32S
-
-
Pietra, G.G.1
Capron, F.2
Stewart, S.3
-
32
-
-
2942541475
-
Cellular and molecular pathobiology of pulmonary arterial hypertension
-
M. Humbert, N.W. Morrell, and S.L. Archer Cellular and molecular pathobiology of pulmonary arterial hypertension J Am Coll Cardiol 43 12 Suppl S 2004 13S 24S
-
(2004)
J Am Coll Cardiol
, vol.4312 SUPPL S
, pp. 13S-24S
-
-
Humbert, M.1
Morrell, N.W.2
Archer, S.L.3
-
33
-
-
84890753066
-
Relevant issues in the pathology and pathobiology of pulmonary hypertension
-
R.M. Tuder, S.L. Archer, and P. Dorfmuller Relevant issues in the pathology and pathobiology of pulmonary hypertension J Am Coll Cardiol 62 2013 D4 D12
-
(2013)
J Am Coll Cardiol
, vol.62
, pp. D4-D12
-
-
Tuder, R.M.1
Archer, S.L.2
Dorfmuller, P.3
-
34
-
-
84902950876
-
Inflammation and immunity in the pathogenesis of pulmonary arterial hypertension
-
M. Rabinovitch, C. Guignabert, and M. Humbert Inflammation and immunity in the pathogenesis of pulmonary arterial hypertension Circ Res 115 2014 165 175
-
(2014)
Circ Res
, vol.115
, pp. 165-175
-
-
Rabinovitch, M.1
Guignabert, C.2
Humbert, M.3
-
35
-
-
84897011026
-
Immune dysregulation and endothelial dysfunction in pulmonary arterial hypertension: A complex interplay
-
A. Huertas, F. Perros, and L. Tu Immune dysregulation and endothelial dysfunction in pulmonary arterial hypertension: a complex interplay Circulation 129 2014 1332 1340
-
(2014)
Circulation
, vol.129
, pp. 1332-1340
-
-
Huertas, A.1
Perros, F.2
Tu, L.3
-
36
-
-
84895529835
-
Proinflammatory cytokine levels are linked to death in pulmonary arterial hypertension
-
J.L. Cracowski, F. Chabot, and J. Labarere Proinflammatory cytokine levels are linked to death in pulmonary arterial hypertension Eur Respir J 43 2014 915 917
-
(2014)
Eur Respir J
, vol.43
, pp. 915-917
-
-
Cracowski, J.L.1
Chabot, F.2
Labarere, J.3
-
37
-
-
84890687841
-
Genetics and genomics of pulmonary arterial hypertension
-
F. Soubrier, W.K. Chung, and R. Machado Genetics and genomics of pulmonary arterial hypertension J Am Coll Cardiol 62 2013 D13 D21
-
(2013)
J Am Coll Cardiol
, vol.62
, pp. D13-D21
-
-
Soubrier, F.1
Chung, W.K.2
Machado, R.3
-
38
-
-
0022479050
-
Primary pulmonary hypertension: Radiographic and scintigraphic patterns of histologic subtypes
-
S. Rich, G.G. Pietra, and K. Kieras Primary pulmonary hypertension: radiographic and scintigraphic patterns of histologic subtypes Ann Intern Med 105 1986 499 502
-
(1986)
Ann Intern Med
, vol.105
, pp. 499-502
-
-
Rich, S.1
Pietra, G.G.2
Kieras, K.3
-
39
-
-
77954758530
-
Survival in patients with idiopathic, familial, and anorexigen-associated pulmonary arterial hypertension in the modern management era
-
M. Humbert, O. Sitbon, and A. Chaouat Survival in patients with idiopathic, familial, and anorexigen-associated pulmonary arterial hypertension in the modern management era Circulation 122 2010 156 163
-
(2010)
Circulation
, vol.122
, pp. 156-163
-
-
Humbert, M.1
Sitbon, O.2
Chaouat, A.3
-
40
-
-
84928964408
-
Validation of two predictive models for survival in pulmonary arterial hypertension
-
[E-pub ahead of print]
-
O. Sitbon, R.L. Benza, and D.B. Badesch Validation of two predictive models for survival in pulmonary arterial hypertension Eur Respir J 2015 Apr 2 [E-pub ahead of print]
-
(2015)
Eur Respir J
-
-
Sitbon, O.1
Benza, R.L.2
Badesch, D.B.3
-
41
-
-
77953661132
-
Guidelines for the echocardiographic assessment of the right heart in adults: A report from the American Society of Echocardiography endorsed by the European Association of Echocardiography, a registered branch of the European Society of Cardiology, and the Canadian Society of Echocardiography
-
quiz 786-8
-
L.G. Rudski, W.W. Lai, and J. Afilalo Guidelines for the echocardiographic assessment of the right heart in adults: a report from the American Society of Echocardiography endorsed by the European Association of Echocardiography, a registered branch of the European Society of Cardiology, and the Canadian Society of Echocardiography J Am Soc Echocardiogr 23 2010 685 713 quiz 786-8
-
(2010)
J Am Soc Echocardiogr
, vol.23
, pp. 685-713
-
-
Rudski, L.G.1
Lai, W.W.2
Afilalo, J.3
-
42
-
-
33845343982
-
Complications of right heart catheterization procedures in patients with pulmonary hypertension in experienced centers
-
M.M. Hoeper, S.H. Lee, and R. Voswinckel Complications of right heart catheterization procedures in patients with pulmonary hypertension in experienced centers J Am Coll Cardiol 48 2006 2546 2552
-
(2006)
J Am Coll Cardiol
, vol.48
, pp. 2546-2552
-
-
Hoeper, M.M.1
Lee, S.H.2
Voswinckel, R.3
-
43
-
-
20544448927
-
Long-term response to calcium channel blockers in idiopathic pulmonary arterial hypertension
-
O. Sitbon, M. Humbert, and X. Jais Long-term response to calcium channel blockers in idiopathic pulmonary arterial hypertension Circulation 111 2005 3105 3111
-
(2005)
Circulation
, vol.111
, pp. 3105-3111
-
-
Sitbon, O.1
Humbert, M.2
Jais, X.3
-
44
-
-
77957907689
-
Exercise hemodynamics enhance diagnosis of early heart failure with preserved ejection fraction
-
B.A. Borlaug, R.A. Nishimura, and P. Sorajja Exercise hemodynamics enhance diagnosis of early heart failure with preserved ejection fraction Circ Heart Fail 3 2010 588 595
-
(2010)
Circ Heart Fail
, vol.3
, pp. 588-595
-
-
Borlaug, B.A.1
Nishimura, R.A.2
Sorajja, P.3
-
45
-
-
79960102033
-
Clinical characteristics of pulmonary hypertension in patients with heart failure and preserved ejection fraction
-
T. Thenappan, S.J. Shah, and M. Gomberg-Maitland Clinical characteristics of pulmonary hypertension in patients with heart failure and preserved ejection fraction Circ Heart Fail 4 2011 257 265
-
(2011)
Circ Heart Fail
, vol.4
, pp. 257-265
-
-
Thenappan, T.1
Shah, S.J.2
Gomberg-Maitland, M.3
-
46
-
-
44149112098
-
Noninvasive differentiation of pulmonary arterial and venous hypertension using conventional and Doppler tissue imaging echocardiography
-
H.J. Willens, J.A. Chirinos, and O. Gomez-Marin Noninvasive differentiation of pulmonary arterial and venous hypertension using conventional and Doppler tissue imaging echocardiography J Am Soc Echocardiogr 21 2008 715 719
-
(2008)
J Am Soc Echocardiogr
, vol.21
, pp. 715-719
-
-
Willens, H.J.1
Chirinos, J.A.2
Gomez-Marin, O.3
-
47
-
-
84886051256
-
LA volume by CMR distinguishes idiopathic from pulmonary hypertension due to HFpEF
-
S.F. Crawley, M.K. Johnson, and H.J. Dargie LA volume by CMR distinguishes idiopathic from pulmonary hypertension due to HFpEF J Am Coll Cardiol Img 6 2013 1120 1121
-
(2013)
J Am Coll Cardiol Img
, vol.6
, pp. 1120-1121
-
-
Crawley, S.F.1
Johnson, M.K.2
Dargie, H.J.3
-
48
-
-
33749525364
-
Exercise and respiratory training improve exercise capacity and quality of life in patients with severe chronic pulmonary hypertension
-
D. Mereles, N. Ehlken, and S. Kreuscher Exercise and respiratory training improve exercise capacity and quality of life in patients with severe chronic pulmonary hypertension Circulation 114 2006 1482 1489
-
(2006)
Circulation
, vol.114
, pp. 1482-1489
-
-
Mereles, D.1
Ehlken, N.2
Kreuscher, S.3
-
49
-
-
0026632785
-
The effect of high doses of calcium-channel blockers on survival in primary pulmonary hypertension
-
S. Rich, E. Kaufmann, and P.S. Levy The effect of high doses of calcium-channel blockers on survival in primary pulmonary hypertension N Engl J Med 327 1992 76 81
-
(1992)
N Engl J Med
, vol.327
, pp. 76-81
-
-
Rich, S.1
Kaufmann, E.2
Levy, P.S.3
-
50
-
-
0030813510
-
The effect of anticoagulant therapy in primary and anorectic drug-induced pulmonary hypertension
-
H. Frank, J. Mlczoch, and K. Huber The effect of anticoagulant therapy in primary and anorectic drug-induced pulmonary hypertension Chest 112 1997 714 721
-
(1997)
Chest
, vol.112
, pp. 714-721
-
-
Frank, H.1
Mlczoch, J.2
Huber, K.3
-
51
-
-
0021193273
-
Primary pulmonary hypertension: Natural history and the importance of thrombosis
-
V. Fuster, P.M. Steele, and W.D. Edwards Primary pulmonary hypertension: natural history and the importance of thrombosis Circulation 70 1984 580 587
-
(1984)
Circulation
, vol.70
, pp. 580-587
-
-
Fuster, V.1
Steele, P.M.2
Edwards, W.D.3
-
52
-
-
84891850978
-
Anticoagulation and survival in pulmonary arterial hypertension: Results from the Comparative, Prospective Registry of Newly Initiated Therapies for Pulmonary Hypertension (COMPERA)
-
K.M. Olsson, M. Delcroix, and H.A. Ghofrani Anticoagulation and survival in pulmonary arterial hypertension: results from the Comparative, Prospective Registry of Newly Initiated Therapies for Pulmonary Hypertension (COMPERA) Circulation 129 2014 57 65
-
(2014)
Circulation
, vol.129
, pp. 57-65
-
-
Olsson, K.M.1
Delcroix, M.2
Ghofrani, H.A.3
-
53
-
-
0033032949
-
Prostacyclin synthase expression is decreased in lungs from patients with severe pulmonary hypertension
-
R.M. Tuder, C.D. Cool, and M.W. Geraci Prostacyclin synthase expression is decreased in lungs from patients with severe pulmonary hypertension Am J Respir Crit Care Med 159 1999 1925 1932
-
(1999)
Am J Respir Crit Care Med
, vol.159
, pp. 1925-1932
-
-
Tuder, R.M.1
Cool, C.D.2
Geraci, M.W.3
-
54
-
-
0030031888
-
A comparison of continuous intravenous epoprostenol (prostacyclin) with conventional therapy for primary pulmonary hypertension
-
Primary Pulmonary Hypertension Study Group
-
R.J. Barst, L.J. Rubin, W.A. Long Primary Pulmonary Hypertension Study Group A comparison of continuous intravenous epoprostenol (prostacyclin) with conventional therapy for primary pulmonary hypertension N Engl J Med 334 1996 296 301
-
(1996)
N Engl J Med
, vol.334
, pp. 296-301
-
-
Barst, R.J.1
Rubin, L.J.2
Long, W.A.3
-
55
-
-
0037126044
-
Survival in primary pulmonary hypertension: The impact of epoprostenol therapy
-
V.V. McLaughlin, A. Shillington, and S. Rich Survival in primary pulmonary hypertension: the impact of epoprostenol therapy Circulation 106 2002 1477 1482
-
(2002)
Circulation
, vol.106
, pp. 1477-1482
-
-
McLaughlin, V.V.1
Shillington, A.2
Rich, S.3
-
56
-
-
0037151645
-
Long-term intravenous epoprostenol infusion in primary pulmonary hypertension: Prognostic factors and survival
-
O. Sitbon, M. Humbert, and H. Nunes Long-term intravenous epoprostenol infusion in primary pulmonary hypertension: prognostic factors and survival J Am Coll Cardiol 40 2002 780 788
-
(2002)
J Am Coll Cardiol
, vol.40
, pp. 780-788
-
-
Sitbon, O.1
Humbert, M.2
Nunes, H.3
-
57
-
-
17144452827
-
Continuous intravenous epoprostenol for pulmonary hypertension due to the scleroderma spectrum of disease. A randomized, controlled trial
-
D.B. Badesch, V.F. Tapson, and M.D. McGoon Continuous intravenous epoprostenol for pulmonary hypertension due to the scleroderma spectrum of disease. A randomized, controlled trial Ann Intern Med 132 2000 425 434
-
(2000)
Ann Intern Med
, vol.132
, pp. 425-434
-
-
Badesch, D.B.1
Tapson, V.F.2
McGoon, M.D.3
-
58
-
-
0037086133
-
Continuous subcutaneous infusion of treprostinil, a prostacyclin analogue, in patients with pulmonary arterial hypertension: A double-blind, randomized, placebo-controlled trial
-
G. Simonneau, R.J. Barst, and N. Galie Continuous subcutaneous infusion of treprostinil, a prostacyclin analogue, in patients with pulmonary arterial hypertension: a double-blind, randomized, placebo-controlled trial Am J Respir Crit Care Med 165 2002 800 804
-
(2002)
Am J Respir Crit Care Med
, vol.165
, pp. 800-804
-
-
Simonneau, G.1
Barst, R.J.2
Galie, N.3
-
59
-
-
77952301237
-
Addition of inhaled treprostinil to oral therapy for pulmonary arterial hypertension: A randomized controlled clinical trial
-
V.V. McLaughlin, R.L. Benza, and L.J. Rubin Addition of inhaled treprostinil to oral therapy for pulmonary arterial hypertension: a randomized controlled clinical trial J Am Coll Cardiol 55 2010 1915 1922
-
(2010)
J Am Coll Cardiol
, vol.55
, pp. 1915-1922
-
-
McLaughlin, V.V.1
Benza, R.L.2
Rubin, L.J.3
-
60
-
-
84873566367
-
Efficacy and safety of oral treprostinil monotherapy for the treatment of pulmonary arterial hypertension: A randomized, controlled trial
-
Z.C. Jing, K. Parikh, and T. Pulido Efficacy and safety of oral treprostinil monotherapy for the treatment of pulmonary arterial hypertension: a randomized, controlled trial Circulation 127 2013 624 633
-
(2013)
Circulation
, vol.127
, pp. 624-633
-
-
Jing, Z.C.1
Parikh, K.2
Pulido, T.3
-
61
-
-
84866515810
-
Oral treprostinil for the treatment of pulmonary arterial hypertension in patients on background endothelin receptor antagonist and/or phosphodiesterase type 5 inhibitor therapy (the FREEDOM-C study): A randomized controlled trial
-
V.F. Tapson, F. Torres, and F. Kermeen Oral treprostinil for the treatment of pulmonary arterial hypertension in patients on background endothelin receptor antagonist and/or phosphodiesterase type 5 inhibitor therapy (the FREEDOM-C study): a randomized controlled trial Chest 142 2012 1383 1390
-
(2012)
Chest
, vol.142
, pp. 1383-1390
-
-
Tapson, V.F.1
Torres, F.2
Kermeen, F.3
-
62
-
-
84880766215
-
Oral treprostinil for the treatment of pulmonary arterial hypertension in patients receiving background endothelin receptor antagonist and phosphodiesterase type 5 inhibitor therapy (the FREEDOM-C2 study): A randomized controlled trial
-
for the FREEDOM-C2 Study Team
-
V.F. Tapson, Z.C. Jing, K.F. Xu for the FREEDOM-C2 Study Team Oral treprostinil for the treatment of pulmonary arterial hypertension in patients receiving background endothelin receptor antagonist and phosphodiesterase type 5 inhibitor therapy (the FREEDOM-C2 study): a randomized controlled trial Chest 144 2013 952 958
-
(2013)
Chest
, vol.144
, pp. 952-958
-
-
Tapson, V.F.1
Jing, Z.C.2
Xu, K.F.3
-
63
-
-
0036682273
-
Inhaled iloprost for severe pulmonary hypertension
-
for the Aerosolized Iloprost Randomized Study Group
-
H. Olschewski, G. Simonneau, N. Galie for the Aerosolized Iloprost Randomized Study Group Inhaled iloprost for severe pulmonary hypertension N Engl J Med 347 2002 322 329
-
(2002)
N Engl J Med
, vol.347
, pp. 322-329
-
-
Olschewski, H.1
Simonneau, G.2
Galie, N.3
-
64
-
-
0026034713
-
Increased plasma endothelin-1 in pulmonary hypertension: Marker or mediator of disease?
-
D.J. Stewart, R.D. Levy, and P. Cernacek Increased plasma endothelin-1 in pulmonary hypertension: marker or mediator of disease? Ann Intern Med 114 1991 464 469
-
(1991)
Ann Intern Med
, vol.114
, pp. 464-469
-
-
Stewart, D.J.1
Levy, R.D.2
Cernacek, P.3
-
65
-
-
0027324745
-
Expression of endothelin-1 in the lungs of patients with pulmonary hypertension
-
A. Giaid, M. Yanagisawa, and D. Langleben Expression of endothelin-1 in the lungs of patients with pulmonary hypertension N Engl J Med 328 1993 1732 1739
-
(1993)
N Engl J Med
, vol.328
, pp. 1732-1739
-
-
Giaid, A.1
Yanagisawa, M.2
Langleben, D.3
-
66
-
-
33846309982
-
Endothelin-1/endothelin-3 ratio: A potential prognostic factor of pulmonary arterial hypertension
-
D. Montani, R. Souza, and C. Binkert Endothelin-1/endothelin-3 ratio: a potential prognostic factor of pulmonary arterial hypertension Chest 131 2007 101 108
-
(2007)
Chest
, vol.131
, pp. 101-108
-
-
Montani, D.1
Souza, R.2
Binkert, C.3
-
67
-
-
0037149718
-
Bosentan therapy for pulmonary arterial hypertension
-
L.J. Rubin, D.B. Badesch, and R.J. Barst Bosentan therapy for pulmonary arterial hypertension N Engl J Med 346 2002 896 903
-
(2002)
N Engl J Med
, vol.346
, pp. 896-903
-
-
Rubin, L.J.1
Badesch, D.B.2
Barst, R.J.3
-
68
-
-
45249119855
-
Treatment of patients with mildly symptomatic pulmonary arterial hypertension with bosentan (EARLY study): A double-blind, randomised controlled trial
-
N. Galie, L. Rubin, and M. Hoeper Treatment of patients with mildly symptomatic pulmonary arterial hypertension with bosentan (EARLY study): a double-blind, randomised controlled trial Lancet 371 2008 2093 2100
-
(2008)
Lancet
, vol.371
, pp. 2093-2100
-
-
Galie, N.1
Rubin, L.2
Hoeper, M.3
-
69
-
-
33746206340
-
Bosentan therapy in patients with Eisenmenger syndrome: A multicenter, double-blind, randomized, placebo-controlled study
-
Bosentan Randomized Trial of Endothelin Antagonist Therapy-5 (BREATHE-5) Investigators
-
N. Galie, M. Beghetti, M.A. Gatzoulis Bosentan Randomized Trial of Endothelin Antagonist Therapy-5 (BREATHE-5) Investigators Bosentan therapy in patients with Eisenmenger syndrome: a multicenter, double-blind, randomized, placebo-controlled study Circulation 114 2006 48 54
-
(2006)
Circulation
, vol.114
, pp. 48-54
-
-
Galie, N.1
Beghetti, M.2
Gatzoulis, M.A.3
-
70
-
-
46449124591
-
Ambrisentan for the treatment of pulmonary arterial hypertension: Results of the ambrisentan in pulmonary arterial hypertension, randomized, double-blind, placebo-controlled, multicenter, efficacy (ARIES) study 1 and 2
-
Ambrisentan in Pulmonary Arterial Hypertension, Randomized, Double-Blind, Placebo-Controlled, Multicenter, Efficacy Studies (ARIES) Group
-
N. Galie, H. Olschewski, R.J. Oudiz Ambrisentan in Pulmonary Arterial Hypertension, Randomized, Double-Blind, Placebo-Controlled, Multicenter, Efficacy Studies (ARIES) Group Ambrisentan for the treatment of pulmonary arterial hypertension: results of the ambrisentan in pulmonary arterial hypertension, randomized, double-blind, placebo-controlled, multicenter, efficacy (ARIES) study 1 and 2 Circulation 117 2008 3010 3019
-
(2008)
Circulation
, vol.117
, pp. 3010-3019
-
-
Galie, N.1
Olschewski, H.2
Oudiz, R.J.3
-
72
-
-
84883108940
-
Macitentan and morbidity and mortality in pulmonary arterial hypertension
-
for the SERAPHIN Investigators
-
T. Pulido, I. Adzerikho, R.N. Channick for the SERAPHIN Investigators Macitentan and morbidity and mortality in pulmonary arterial hypertension N Engl J Med 369 2013 809 818
-
(2013)
N Engl J Med
, vol.369
, pp. 809-818
-
-
Pulido, T.1
Adzerikho, I.2
Channick, R.N.3
-
73
-
-
0029055964
-
Reduced expression of endothelial nitric oxide synthase in the lungs of patients with pulmonary hypertension
-
A. Giaid, and D. Saleh Reduced expression of endothelial nitric oxide synthase in the lungs of patients with pulmonary hypertension N Engl J Med 333 1995 214 221
-
(1995)
N Engl J Med
, vol.333
, pp. 214-221
-
-
Giaid, A.1
Saleh, D.2
-
74
-
-
26444534291
-
Sildenafil citrate therapy for pulmonary arterial hypertension
-
for the Sildenafil Use in Pulmonary Arterial Hypertension (SUPER) Study Group
-
N. Galie, H.A. Ghofrani, A. Torbicki for the Sildenafil Use in Pulmonary Arterial Hypertension (SUPER) Study Group Sildenafil citrate therapy for pulmonary arterial hypertension N Engl J Med 353 2005 2148 2157
-
(2005)
N Engl J Med
, vol.353
, pp. 2148-2157
-
-
Galie, N.1
Ghofrani, H.A.2
Torbicki, A.3
-
75
-
-
67649523052
-
Tadalafil therapy for pulmonary arterial hypertension
-
for the Pulmonary Arterial Hypertension and Response to Tadalafil (PHIRST) Study Group
-
N. Galie, B.H. Brundage, H.A. Ghofrani for the Pulmonary Arterial Hypertension and Response to Tadalafil (PHIRST) Study Group Tadalafil therapy for pulmonary arterial hypertension Circulation 119 2009 2894 2903
-
(2009)
Circulation
, vol.119
, pp. 2894-2903
-
-
Galie, N.1
Brundage, B.H.2
Ghofrani, H.A.3
-
76
-
-
63849256355
-
First acute haemodynamic study of soluble guanylate cyclase stimulator riociguat in pulmonary hypertension
-
F. Grimminger, G. Weimann, and R. Frey First acute haemodynamic study of soluble guanylate cyclase stimulator riociguat in pulmonary hypertension Eur Respir J 33 2009 785 792
-
(2009)
Eur Respir J
, vol.33
, pp. 785-792
-
-
Grimminger, F.1
Weimann, G.2
Frey, R.3
-
77
-
-
79958128614
-
Soluble guanylate cyclase as an emerging therapeutic target in cardiopulmonary disease
-
J.P. Stasch, P. Pacher, and O.V. Evgenov Soluble guanylate cyclase as an emerging therapeutic target in cardiopulmonary disease Circulation 123 2011 2263 2273
-
(2011)
Circulation
, vol.123
, pp. 2263-2273
-
-
Stasch, J.P.1
Pacher, P.2
Evgenov, O.V.3
-
78
-
-
84880732460
-
Riociguat for the treatment of chronic thromboembolic pulmonary hypertension
-
for the CHEST-1 Study Group
-
H.A. Ghofrani, A.M. D'Armini, F. Grimminger for the CHEST-1 Study Group Riociguat for the treatment of chronic thromboembolic pulmonary hypertension N Engl J Med 369 2013 319 329
-
(2013)
N Engl J Med
, vol.369
, pp. 319-329
-
-
Ghofrani, H.A.1
D'Armini, A.M.2
Grimminger, F.3
-
79
-
-
84880721470
-
Riociguat for the treatment of pulmonary arterial hypertension
-
for the PATENT-1 Study Group
-
H.A. Ghofrani, N. Galie, F. Grimminger for the PATENT-1 Study Group Riociguat for the treatment of pulmonary arterial hypertension N Engl J Med 369 2013 330 340
-
(2013)
N Engl J Med
, vol.369
, pp. 330-340
-
-
Ghofrani, H.A.1
Galie, N.2
Grimminger, F.3
-
80
-
-
81455150149
-
Intensive care unit management of patients with severe pulmonary hypertension and right heart failure
-
M.M. Hoeper, and J. Granton Intensive care unit management of patients with severe pulmonary hypertension and right heart failure Am J Respir Crit Care Med 184 2011 1114 1124
-
(2011)
Am J Respir Crit Care Med
, vol.184
, pp. 1114-1124
-
-
Hoeper, M.M.1
Granton, J.2
-
81
-
-
77955917444
-
Long-term outcome of double-lung and heart-lung transplantation for pulmonary hypertension: A comparative retrospective study of 219 patients
-
E. Fadel, O. Mercier, and S. Mussot Long-term outcome of double-lung and heart-lung transplantation for pulmonary hypertension: a comparative retrospective study of 219 patients Eur J Cardiothorac Surg 38 2010 277 284
-
(2010)
Eur J Cardiothorac Surg
, vol.38
, pp. 277-284
-
-
Fadel, E.1
Mercier, O.2
Mussot, S.3
-
83
-
-
84917735274
-
Advances in therapeutic interventions for patients with pulmonary arterial hypertension
-
M. Humbert, E.M. Lau, and D. Montani Advances in therapeutic interventions for patients with pulmonary arterial hypertension Circulation 130 2014 2189 2208
-
(2014)
Circulation
, vol.130
, pp. 2189-2208
-
-
Humbert, M.1
Lau, E.M.2
Montani, D.3
-
84
-
-
82555189244
-
Effect of atrial septostomy on the survival of patients with severe pulmonary arterial hypertension
-
J. Sandoval, J. Gaspar, and H. Pena Effect of atrial septostomy on the survival of patients with severe pulmonary arterial hypertension Eur Respir J 38 2011 1343 1348
-
(2011)
Eur Respir J
, vol.38
, pp. 1343-1348
-
-
Sandoval, J.1
Gaspar, J.2
Pena, H.3
-
85
-
-
84901855893
-
Upfront triple combination therapy in pulmonary arterial hypertension: A pilot study
-
O. Sitbon, X. Jais, and L. Savale Upfront triple combination therapy in pulmonary arterial hypertension: a pilot study Eur Respir J 43 2014 1691 1697
-
(2014)
Eur Respir J
, vol.43
, pp. 1691-1697
-
-
Sitbon, O.1
Jais, X.2
Savale, L.3
-
87
-
-
84905654511
-
Pharmacologic therapy for pulmonary arterial hypertension in adults: CHEST guideline and expert panel report
-
D.B. Taichman, J. Ornelas, and L. Chung Pharmacologic therapy for pulmonary arterial hypertension in adults: CHEST guideline and expert panel report Chest 146 2014 449 475
-
(2014)
Chest
, vol.146
, pp. 449-475
-
-
Taichman, D.B.1
Ornelas, J.2
Chung, L.3
-
88
-
-
84890749305
-
The Fifth World Symposium on Pulmonary Hypertension
-
N. Galie, and G. Simonneau The Fifth World Symposium on Pulmonary Hypertension J Am Coll Cardiol 62 Suppl D 2013 D1 D3
-
(2013)
J Am Coll Cardiol
, vol.62
, pp. D1-D3
-
-
Galie, N.1
Simonneau, G.2
-
89
-
-
84863528040
-
Selexipag: An oral, selective prostacyclin receptor agonist for the treatment of pulmonary arterial hypertension
-
G. Simonneau, A. Torbicki, and M.M. Hoeper Selexipag: an oral, selective prostacyclin receptor agonist for the treatment of pulmonary arterial hypertension Eur Respir J 40 2012 874 880
-
(2012)
Eur Respir J
, vol.40
, pp. 874-880
-
-
Simonneau, G.1
Torbicki, A.2
Hoeper, M.M.3
-
90
-
-
84928964409
-
Effect of selexipag on morbidity/mortality in pulmonary arterial hyertension: Results of the GRIPHON study
-
March 15, San Diego, CA
-
McLaughlin VV. Effect of selexipag on morbidity/mortality in pulmonary arterial hyertension: results of the GRIPHON study. Paper presented at: ACC.15; March 15, 2015; San Diego, CA.
-
(2015)
Paper Presented At: ACC.15
-
-
McLaughlin, V.V.1
-
91
-
-
84874948946
-
Imatinib mesylate as add-on therapy for pulmonary arterial hypertension: Results of the randomized IMPRES study
-
M.M. Hoeper, R.J. Barst, and R.C. Bourge Imatinib mesylate as add-on therapy for pulmonary arterial hypertension: results of the randomized IMPRES study Circulation 127 2013 1128 1138
-
(2013)
Circulation
, vol.127
, pp. 1128-1138
-
-
Hoeper, M.M.1
Barst, R.J.2
Bourge, R.C.3
-
92
-
-
33646201514
-
Cross talk between endothelial and smooth muscle cells in pulmonary hypertension: Critical role for serotonin-induced smooth muscle hyperplasia
-
S. Eddahibi, C. Guignabert, and A.M. Barlier-Mur Cross talk between endothelial and smooth muscle cells in pulmonary hypertension: critical role for serotonin-induced smooth muscle hyperplasia Circulation 113 2006 1857 1864
-
(2006)
Circulation
, vol.113
, pp. 1857-1864
-
-
Eddahibi, S.1
Guignabert, C.2
Barlier-Mur, A.M.3
-
93
-
-
84884603855
-
Double-blind, placebo-controlled clinical trial with a rho-kinase inhibitor in pulmonary arterial hypertension
-
Y. Fukumoto, N. Yamada, and H. Matsubara Double-blind, placebo-controlled clinical trial with a rho-kinase inhibitor in pulmonary arterial hypertension Circ J 77 2013 2619 2625
-
(2013)
Circ J
, vol.77
, pp. 2619-2625
-
-
Fukumoto, Y.1
Yamada, N.2
Matsubara, H.3
-
94
-
-
39749156384
-
Immunosuppressive therapy in lupus- and mixed connective tissue disease-associated pulmonary arterial hypertension: A retrospective analysis of twenty-three cases
-
X. Jais, D. Launay, and A. Yaici Immunosuppressive therapy in lupus- and mixed connective tissue disease-associated pulmonary arterial hypertension: a retrospective analysis of twenty-three cases Arthritis Rheum 58 2008 521 531
-
(2008)
Arthritis Rheum
, vol.58
, pp. 521-531
-
-
Jais, X.1
Launay, D.2
Yaici, A.3
-
96
-
-
0037080541
-
Dichloroacetate, a metabolic modulator, prevents and reverses chronic hypoxic pulmonary hypertension in rats: Role of increased expression and activity of voltage-gated potassium channels
-
E.D. Michelakis, M.S. McMurtry, and X.C. Wu Dichloroacetate, a metabolic modulator, prevents and reverses chronic hypoxic pulmonary hypertension in rats: role of increased expression and activity of voltage-gated potassium channels Circulation 105 2002 244 250
-
(2002)
Circulation
, vol.105
, pp. 244-250
-
-
Michelakis, E.D.1
McMurtry, M.S.2
Wu, X.C.3
-
97
-
-
84928964411
-
-
Dichloroacetate (DCA) for the treatment of pulmonary arterial hypertension Accessed March 15, 2015
-
ClinicalTrials.gov. Dichloroacetate (DCA) for the treatment of pulmonary arterial hypertension. 2014. Available at: https://clinicaltrials.gov/ct2/show/NCT01083524. Accessed March 15, 2015.
-
(2014)
-
-
-
98
-
-
84881240287
-
FK506 activates BMPR2, rescues endothelial dysfunction, and reverses pulmonary hypertension
-
E. Spiekerkoetter, X. Tian, and J. Cai FK506 activates BMPR2, rescues endothelial dysfunction, and reverses pulmonary hypertension J Clin Invest 123 2013 3600 3613
-
(2013)
J Clin Invest
, vol.123
, pp. 3600-3613
-
-
Spiekerkoetter, E.1
Tian, X.2
Cai, J.3
-
99
-
-
34047108549
-
Transplantation of autologous endothelial progenitor cells may be beneficial in patients with idiopathic pulmonary arterial hypertension: A pilot randomized controlled trial
-
X.X. Wang, F.R. Zhang, and Y.P. Shang Transplantation of autologous endothelial progenitor cells may be beneficial in patients with idiopathic pulmonary arterial hypertension: a pilot randomized controlled trial J Am Coll Cardiol 49 2007 1566 1571
-
(2007)
J Am Coll Cardiol
, vol.49
, pp. 1566-1571
-
-
Wang, X.X.1
Zhang, F.R.2
Shang, Y.P.3
-
100
-
-
84867589328
-
Dysregulated renin-angiotensin-aldosterone system contributes to pulmonary arterial hypertension
-
F.S. de Man, L. Tu, and M.L. Handoko Dysregulated renin-angiotensin-aldosterone system contributes to pulmonary arterial hypertension Am J Respir Crit Care Med 186 2012 780 789
-
(2012)
Am J Respir Crit Care Med
, vol.186
, pp. 780-789
-
-
De Man, F.S.1
Tu, L.2
Handoko, M.L.3
-
101
-
-
77957694135
-
Adrenergic receptor blockade reverses right heart remodeling and dysfunction in pulmonary hypertensive rats
-
H.J. Bogaard, R. Natarajan, and S. Mizuno Adrenergic receptor blockade reverses right heart remodeling and dysfunction in pulmonary hypertensive rats Am J Respir Crit Care Med 182 2010 652 660
-
(2010)
Am J Respir Crit Care Med
, vol.182
, pp. 652-660
-
-
Bogaard, H.J.1
Natarajan, R.2
Mizuno, S.3
-
102
-
-
84883753645
-
Pulmonary artery denervation to treat pulmonary arterial hypertension: The single-center, prospective, first-in-man PADN-1 study (first-in-man pulmonary artery denervation for treatment of pulmonary artery hypertension)
-
S.L. Chen, F.F. Zhang, and J. Xu Pulmonary artery denervation to treat pulmonary arterial hypertension: the single-center, prospective, first-in-man PADN-1 study (first-in-man pulmonary artery denervation for treatment of pulmonary artery hypertension) J Am Coll Cardiol 62 2013 1092 1100
-
(2013)
J Am Coll Cardiol
, vol.62
, pp. 1092-1100
-
-
Chen, S.L.1
Zhang, F.F.2
Xu, J.3
-
103
-
-
84928175500
-
Palliative Potts shunt for the treatment of children with drug-refractory pulmonary arterial hypertension: Updated data from the first 24 patients
-
A.E. Baruteau, E. Belli, and Y. Boudjemline Palliative Potts shunt for the treatment of children with drug-refractory pulmonary arterial hypertension: updated data from the first 24 patients Eur J Cardiothorac Surg 47 2015 e105 e110
-
(2015)
Eur J Cardiothorac Surg
, vol.47
, pp. e105-e110
-
-
Baruteau, A.E.1
Belli, E.2
Boudjemline, Y.3
-
104
-
-
84875210519
-
Transcatheter Potts shunt creation in patients with severe pulmonary arterial hypertension: Initial clinical experience
-
J.J. Esch, P.B. Shah, and B.A. Cockrill Transcatheter Potts shunt creation in patients with severe pulmonary arterial hypertension: initial clinical experience J Heart Lung Transplant 32 2013 381 387
-
(2013)
J Heart Lung Transplant
, vol.32
, pp. 381-387
-
-
Esch, J.J.1
Shah, P.B.2
Cockrill, B.A.3
-
105
-
-
84878772028
-
Outcomes of noncardiac, nonobstetric surgery in patients with PAH: An international prospective survey
-
S. Meyer, V.V. McLaughlin, and H.J. Seyfarth Outcomes of noncardiac, nonobstetric surgery in patients with PAH: an international prospective survey Eur Respir J 41 2013 1302 1307
-
(2013)
Eur Respir J
, vol.41
, pp. 1302-1307
-
-
Meyer, S.1
McLaughlin, V.V.2
Seyfarth, H.J.3
-
106
-
-
84871280711
-
Pulmonary hypertension in pregnancy: Critical care management
-
A.M. Bassily-Marcus, C. Yuan, and J. Oropello Pulmonary hypertension in pregnancy: critical care management Pulmonary Med 2012 2012 709407
-
(2012)
Pulmonary Med
, vol.2012
, pp. 709407
-
-
Bassily-Marcus, A.M.1
Yuan, C.2
Oropello, J.3
-
107
-
-
21144466750
-
Severe pulmonary hypertension during pregnancy
-
M. Bonnin, F.J. Mercier, and O. Sitbon Severe pulmonary hypertension during pregnancy Anesthesiology 102 2005 1133 1137
-
(2005)
Anesthesiology
, vol.102
, pp. 1133-1137
-
-
Bonnin, M.1
Mercier, F.J.2
Sitbon, O.3
-
108
-
-
84865577863
-
Pregnancy outcomes in pulmonary arterial hypertension in the modern management era
-
X. Jais, K.M. Olsson, and J.A. Barbera Pregnancy outcomes in pulmonary arterial hypertension in the modern management era Eur Respir J 40 2012 881 885
-
(2012)
Eur Respir J
, vol.40
, pp. 881-885
-
-
Jais, X.1
Olsson, K.M.2
Barbera, J.A.3
-
109
-
-
34548644211
-
Use of Tandem Heart as a temporary hemodynamic support option for severe pulmonary artery hypertension complicated by cardiogenic shock
-
S. Rajdev, R. Benza, and V. Misra Use of Tandem Heart as a temporary hemodynamic support option for severe pulmonary artery hypertension complicated by cardiogenic shock J Invasive Cardiol 19 2007 E226 E229
-
(2007)
J Invasive Cardiol
, vol.19
, pp. E226-E229
-
-
Rajdev, S.1
Benza, R.2
Misra, V.3
-
110
-
-
84876545515
-
Use of the Impella 2.5 Microaxial pump for right ventricular support after insertion of Heartmate II left ventricular assist device
-
M.B. Anderson, and M. O'Brien Use of the Impella 2.5 Microaxial pump for right ventricular support after insertion of Heartmate II left ventricular assist device Ann Thorac Surg 95 2013 e109 e110
-
(2013)
Ann Thorac Surg
, vol.95
, pp. e109-e110
-
-
Anderson, M.B.1
O'Brien, M.2
-
111
-
-
84878491606
-
Referral of patients with pulmonary hypertension diagnoses to tertiary pulmonary hypertension centers: The multicenter RePHerral study
-
R.C. Deano, C. Glassner-Kolmin, and M. Rubenfire Referral of patients with pulmonary hypertension diagnoses to tertiary pulmonary hypertension centers: the multicenter RePHerral study JAMA Int Med 173 2013 887 893
-
(2013)
JAMA Int Med
, vol.173
, pp. 887-893
-
-
Deano, R.C.1
Glassner-Kolmin, C.2
Rubenfire, M.3
|